UCSF 40th Annual Advances In Heart Disease 2023

Our 40th annual course will again strive to present topics that highlight new evidence-based medicine findings reported within the last one to two years that impact clinical practice. These will range across a variety of cardiologic subspecialty interests including heart failure, arrhythmias, cardiac surgery, gene therapy, aortic diseases, prevention and artificial intelligence. Our faculty will include a distinguished group of visiting academicians along with outstanding teachers and clinicians from the University of California, San Francisco

Objectives:

An attendee completing this course should be able to:

• Provide the best management of coronary heart disease, hypertension, lipid disorders, diabetes, systolic and diastolic heart failure, atrial fibrillation and flutter, STEMI and non-STEMI, thromboembolic disease
• Refine considerations for atrial fibrillation, atrial flutter, and ventricular tachycardia ablation
• Apply he best considerations of percutaneous interventions for coronary heart disease
• Improve the use of anti-platelet and anti-coagulation therapy for cardiovascular diseases
• Identify risk stratification of cardiovascular disease
• Optimize management of peripheral artery disease
• Identify and treat accordingly, the differing pathophysiology of diseases and treatment options among racial and ethnic groups
• Enhance management of COVID-19 and its cardiovascular complications

Course Outline:

Friday, December 8, 2023
7:00 AM Registration and Continental Breakfast
8:10 Welcome and Symposium Overview Priscilla Hsue, MD
Session: Frontiers in Cardiology: Artificial Intelligence and the Heart, Updates in Pulmonary
Hypertension and Peripheral Vascular Disease- Chair: Priscilla Hsue, MD
8:15 Artificial Intelligence and Cardiology Debate:
Sonographer vs. AI
David Ouyang, MD
8:55 Myocarditis: Where Are We in 2023? Bettina Heidecker, MD
9:35 Genetics, Artificial Intelligence and the
Heart
James Pirruccello, MD
10:15 Coffee Break
10:30 Pulmonary Hypertension – What is New in 2023 Marc Simon, MD
11:10 Peripheral Vascular Disease Updates in 2023 Eric Secemsky, MD
11:50 Elliot Rapaport Keynote Lecture:
Earning Trust: The Heart of the Matter
Julie Gerberding MD
12:40 PM Lunch (on Your Own)
Session: New Approaches to Improving Outcomes in Heart Failure, Valve Disease, Pulmonary
Embolism and Cardiac Arrest Chair: Lucas Zier, MD, MS
2:00 Interventional Approaches to Heart Failure Lucas Zier, MD, MS
2:40 Improving Outcomes in Acute Pulmonary
Embolism
Antonio Gomez, MD
3:20 Neuroprotection Strategies After Cardiac Arrest Claude Hemphill, MD
4:00 Coffee Break
4:15 Modern Role of the Ross Procedure in the
Treatment of Aortic Valve Disease
Marko Boskovski, MD, MHS, MPH
4:55 The Current State and Future Direction of
Critical Care Cardiology
Chris Barnett, MD and Connor
O’Brien, MD
5:35 Adjourn
Saturday, December 9, 2023
7:30 AM Continental Breakfast
8:05 Announcements Priscilla Hsue, MD
Session: Advances and Controversies in Electrophysiology Chair: Nora Goldschlager, MD
8:10 Debate: Older Patients with High CHADS-VASC
and Bleeding Risk Should Have Left Atrial
Appendage Closed
Tommy Dewland, MD (pro)
Adam Lee, MD (con)
8:50 Pacing for Heart Failure with Preserved Ejection
Fraction
Ram Venkateswaran, MD
9:30 Debate: Treatment for Symptomatic Atrial
Fibrillation First-line Ablation vs.
Pharmacologic Therapy
Ed Gerstenfeld, MD
Joshua Moss MD
10:10 Coffee Break
10:25 New Technologies in Pacing for Central
Sleep Apnea and Heart Failure
Byron Lee, MD
11:05 The Effect of Alcohol, Caffeine and Tobacco on
Atrial Fibrillation – Are Any Vices OK?
Gregory Marcus, MD, MAS
11:45 Lunch (on your own)
Session: Managing Heart Failure Chair: Jonathan Davis, MD, MPHS
1:30 PM Polypharmacy and Medication Costs for Guideline
Directed Medical Therapy for Patients with Heart
Failure with Reduced Ejection Fraction
Rose Pavlakos PharmD
2:10 Remote Monitoring of Patients with Heart Failure Liviu Klein, MD, MS
2:50 Right Ventricular Heart Failure Brian Houston, MD
3:30 Coffee Break
3:45 Review of Guideline for and Management of Heart
Failure
Jonathan Davis, MD, MPHS
4:25 Approach to Multivessel Coronary Artery Disease
in Patients with Reduced Ejection Fraction
Amy Fiedler, MD and
Krishan Soni, MD, MBA
5:05 PM Adjourn
Sunday, December 10, 2023
7:30 AM Continental Breakfast
8:00 Announcements Priscilla Hsue, MD
Session: Managing Cardiovascular Risk Chair: Peter Ganz, MD
8:05 Clonal Hematopoiesis of
Indeterminate Potential (CHIP): A
Novel Cardiovascular Risk Factor
Peter Libby, MD
8:45 Lipid Management Beyond Statins: What, Why,
and Who?
Christie Ballantyne, MD
9:25 Lp(a): Why is It Important? Michelle O’Donoghue, MD, MPH
10:05 Weight Loss and Cardiovascular Risk: Current
Concepts
Sarah Kim, MD
10:45 Making Sense of Popular Diets: Alignment with
AHA 2021 Dietary Guidance
Christopher Gardner, PhD
11:25 Adjourn